Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou NoroBio Pharmaceutical is a Chinese pharmaceutical company specializing in the manufacturing, sourcing, and global marketing of generic drugs, OTC products, and biological products. Founded in 1983, the company has evolved from a family business into a knowledge-driven biopharmaceutical supplier with a diverse portfolio of finished dosage forms. NoroBio provides a wide range of products, including anti-infectives, antimalarials, anesthetics, and nutritional supplements, and offers OEM manufacturing services under GMP and ISO standards. The company is active in international government tenders and exports to various regions, including Africa, Southeast Asia, and Europe, with a focus on providing affordable and effective medicines. Their product line features high-demand treatments such as Semaglutide injection and various intravenous infusions, supported by a dedicated R&D and quality assurance team.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NoroBio Pharmaceutical.